Skip to main content

Krystal Biotech, Inc.

KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711279

In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

Members of Congress who traded KRYS

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
1 / 0
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded KRYS
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Chris JacobsRepublican · House · NY11 / 0$8.00KDec 12, 2022Jan 20, 2023

Trades

Every reported trade in Krystal Biotech, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Chris JacobsRepublican · House · NYKRYSKrystal Biotech, Inc.BuySelfDec 12, 2022Jan 20, 202339 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.